On Tuesday, Guardant Health Inc (NASDAQ: GH) was 0.47% up from the session before settling in for the closing price of $49.30. A 52-week range for GH has been $20.14 – $52.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 28.08% over the past five years. When this article was written, the company’s average yearly earnings per share was at 22.63%. With a float of $117.74 million, this company’s outstanding shares have now reached $123.65 million.
Let’s look at the performance matrix of the company that is accounted for 2021 employees. In terms of profitability, gross margin is 61.34%, operating margin of -58.78%, and the pretax margin is -53.67%.
Guardant Health Inc (GH) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Guardant Health Inc stocks. The insider ownership of Guardant Health Inc is 4.96%, while institutional ownership is 96.70%. The most recent insider transaction that took place on Jun 17 ’25, was worth 322,818. Before that another transaction happened on Jun 16 ’25, when Company’s Director sold 2,626 for $49.70, making the entire transaction worth $130,512. This insider now owns 18,180 shares in total.
Guardant Health Inc (GH) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 22.63% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.91% during the next five years compared to -33.61% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
You can see what Guardant Health Inc (GH) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.38, a number that is poised to hit -0.72 in the next quarter and is forecasted to reach -2.33 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Guardant Health Inc (NASDAQ: GH) saw its 5-day average volume 1.85 million, a negative change from its year-to-date volume of 2.33 million. As of the previous 9 days, the stock’s Stochastic %D was 78.73%. Additionally, its Average True Range was 2.41.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 81.21%, which indicates a significant decrease from 91.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.51% in the past 14 days, which was lower than the 64.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $43.99, while its 200-day Moving Average is $36.48. Nevertheless, the first resistance level for the watch stands at $50.41 in the near term. At $51.28, the stock is likely to face the second major resistance level. The third major resistance level sits at $52.49. If the price goes on to break the first support level at $48.33, it is likely to go to the next support level at $47.12. The third support level lies at $46.25 if the price breaches the second support level.
Guardant Health Inc (NASDAQ: GH) Key Stats
There are 123,888K outstanding shares of the company, which has a market capitalization of 6.14 billion. As of now, sales total 739,020 K while income totals -436,370 K. Its latest quarter income was 203,470 K while its last quarter net income were -95,160 K.
